|
|
|
| An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D. | Hilary Eaton, Ph.D. was a self-described AI skeptic, particularly regarding using the tool in drug discovery. Then, a series of professional and deeply personal life events and medical discoveries put her in a position to confront that skepticism head-on. On Business of Biotech, the Chief Business Officer at ProFluent Bio shares her story and makes a pragmatic case for the transformative value of AI to biotech builders. Listen now! |
|
|
FOCUS ON UPSTREAM MANUFACTURING |
|
|
|
By Matthew Pillar, Editor, Bioprocess Online
| Experts from FyoniBio, SOTIO, and Vera Therapeutics weigh in with first-hand experience on how process decisions made very early on can influence – beneficially or detrimentally – the efficiency of upstream and even downstream operations in developing novel protein therapeutics. |
|
|
|
|
| Achieve Scalable And High Recovery In rAAV Harvest Process | Webinar | Avantor | Explore research on a biodegradable cell lysis solution paired with a quality endonuclease, offering improved particle protection during agitation, reduced foaming and viscosity, and room-temperature storage and shipping. |
|
|
| Mammalian Bioreactors: A Characterization Data Report | Application Note | By Helen Luo, Collin Edington, and Kris Tyner, Culture Biosciences | Review experiments that characterize the basic operating conditions of mammalian cultures in single-use bioreactors and parameters to be used when transferring cultures to/from other bioreactor systems. |
|
|
| Democratizing Organ-On-A-Chip Technology | Webinar | Emulate | Learn about drug development challenges, the evolution of in vitro cell culture towards greater human relevance, a complete solution for creating human-relevant and translatable models, and more. |
|
|
|
|
|
|
|
|
UPSTREAM MANUFACTURING SOLUTIONS |
|
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
